Clinical trials
Completed Basal Cell Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
99 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2003 | 1 |
| 2004 | 7 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 2 |
| 2009 | 7 |
| 2010 | 4 |
| 2011 | 7 |
| 2012 | 6 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 99 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| UCSF Benioff Children's Hospital Oakland | 5 |
| Memorial Sloan Kettering Cancer Center | 4 |
| National Cancer Institute (NCI) | 4 |
| Roswell Park Cancer Institute | 4 |
| Stanford University | 4 |
| Genentech, Inc. | 3 |
| Massachusetts General Hospital | 3 |
| Northwestern University | 3 |
| Novartis Pharmaceuticals | 3 |
| Regeneron Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Basal Cell Carcinoma | 99 |
| Skin Neoplasms | 26 |
| Carcinoma, Squamous Cell | 25 |
| Melanoma | 15 |
| Basal Cell Nevus Syndrome | 10 |
| Cutaneous Squamous Cell Carcinoma | 5 |
| Keratosis, Actinic | 5 |
| Neoplasms | 5 |
| Neoplasms, Basal Cell | 4 |
| Precancerous Conditions | 4 |
Trials
Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.